Pharmaceutical News

RSS

Drug used for treating rheumatoid arthritis can improve health of kidney transplant recipients

UC San Francisco is the lead institution on a new seven-year, $17 million multicenter study funded by the National Institutes of Health to determine if certain immune system cells and/or a drug now used for treating rheumatoid arthritis can be effective in improving and maintaining the long-term health of kidney transplant recipients.

5 Aug 2014

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a Kaiser Permanente study published today in the journal Clinical Infectious Diseases.

5 Aug 2014

New, promising approach combines metformin and SGLT2 inhibitors to treat diabetes

Various active substances in oral antidiabetic agents are frequently combined in the treatment of diabetes in order to achieve an effective reduction in the blood sugar. A new, very promising approach combines the substances metformin and SGLT2 inhibitors, the latter were just approved in 2012.

4 Aug 2014

Metformin and SGLT2 inhibitors together reduce blood sugar levels

Metformin and SGLT2 inhibitors together reduce the blood sugar levels considerably more effectively than either drug alone.

4 Aug 2014

New use for old drug provides hope for patients with pancreatic cancer

Cancer Research UK scientists have found a new use for an old drug by showing that it shrinks a particular type of pancreatic cancer tumour and stops it spreading, according to research published in Gut.

4 Aug 2014

Artesunate drug can be used to control asthma, finds NUS study

Asthmatic patients may soon have a more effective way to control the condition, thanks to a new pharmacological discovery by researchers from the National University of Singapore.

3 Aug 2014

Common herbal-based anti-malarial drug can be used to control asthma, shows study

Asthmatic patients may soon have a more effective way to control the condition, thanks to a new pharmacological discovery by researchers from the National University of Singapore (NUS).

1 Aug 2014

Study shows sustained immunogenicity, efficacy and safety of GlaxoSmithKline's HPV vaccine

A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix.

1 Aug 2014

Birth control pills may increase risk for breast cancer

Women who recently used birth control pills containing high-dose estrogen and a few other formulations had an increased risk for breast cancer, whereas women using some other formulations did not, according to data published in Cancer Research, a journal of the American Association for Cancer Research.

1 Aug 2014

Researchers identify possible new drug target for treating childhood blood cancer

In what is believed to be the largest genetic analysis of what triggers and propels progression of tumor growth in a common childhood blood cancer, researchers at NYU Langone Medical Center report that they have identified a possible new drug target for treating the disease.

1 Aug 2014

Combination therapy effective in treating drug-resistant malaria

Resistance to artemisinin, the main drug to treat malaria, is now widespread throughout Southeast Asia, among the Plasmodium falciparum (P. falciparum) parasites that cause the disease and is likely caused by a genetic mutation in the parasites.

31 Jul 2014

Anti-cholinergic drugs could be responsible for decline in cognitive, physical function in elderly patients

Drugs widely prescribed to the elderly could be responsible for a decline in cognitive and physical function according to research from the University of East Anglia and the Regenstrief Institute.

31 Jul 2014

Statin therapy may speed up wound healing following cardiac surgery

Statin therapy may help to improve wound healing in patients following cardiac surgery and reduce overall recovery time, especially in patients who are prone to healing complications, according to a review article in the August 2014 issue of The Annals of Thoracic Surgery.

31 Jul 2014

Regeneron announces FDA approval of EYLEA Injection for DME treatment

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

31 Jul 2014

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics (SmPC) for Vipidia (alogliptin) and the fixed-dose combination (FDC) therapies Vipdomet (alogliptin and metformin) and Incresync (alogliptin and pioglitazone).

30 Jul 2014

Pharma forced to adapt their promotional models

In an era of austerity, governments are focusing on value. Value is being defined by primary and secondary health outcomes for citizens, and medicines are just part of the treatment. This is forcing pharma to adopt a broader context in their promotional models, integrating services into the mix, providing patient support and increasing patient empowerment so that products are used optimally and contribute to the best outcomes possible.

30 Jul 2014

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S.

29 Jul 2014

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

29 Jul 2014

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorisation for IMBRUVICA (ibrutinib) in the European Union.

29 Jul 2014

Doctors remind parents about importance of immunizing children

Doctors at Cincinnati Children's Hospital Medical Center want to remind parents about the importance of immunizing their children when preparing to send the children back to school.

29 Jul 2014

Pharmaceutical News

Drug used for treating rheumatoid arthritis can improve health of kidney transplant recipients

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

New, promising approach combines metformin and SGLT2 inhibitors to treat diabetes

Metformin and SGLT2 inhibitors together reduce blood sugar levels

New use for old drug provides hope for patients with pancreatic cancer

Artesunate drug can be used to control asthma, finds NUS study

Common herbal-based anti-malarial drug can be used to control asthma, shows study

Study shows sustained immunogenicity, efficacy and safety of GlaxoSmithKline's HPV vaccine

Birth control pills may increase risk for breast cancer

Researchers identify possible new drug target for treating childhood blood cancer

Combination therapy effective in treating drug-resistant malaria

Anti-cholinergic drugs could be responsible for decline in cognitive, physical function in elderly patients

Statin therapy may speed up wound healing following cardiac surgery

Regeneron announces FDA approval of EYLEA Injection for DME treatment

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

Pharma forced to adapt their promotional models

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Doctors remind parents about importance of immunizing children

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News